Show
Sort by
-
- Journal Article
- A1
- open access
Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial
-
Efficacy and safety of Bimagrumab in sporadic inclusion body myositis : long-term extension of RESILIENT
-
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT) : a randomised, double-blind, placebo-controlled phase 2b trial
-
Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate